Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged over 18 years
- People who have been diagnosed with primary peripheral lung cancer (a specific type and location of lung tumour) confirmed by a pathology test, and whose cancer has been staged as Stage IA (T1N0M0) before any treatment
- People whose tumour has been assessed by doctors as suitable for a type of ablation (a procedure that destroys tumour tissue) guided by CT scan and bronchoscopy (a camera inserted into the airways)
- People who have been assessed as not suitable for surgery, or who have chosen not to have surgery, and who agree to have ablation as their first treatment and have signed a consent form
Who may not be able to join:
- People with a very low platelet count or serious blood clotting problems that cannot be corrected quickly
- People with severe lung scarring (pulmonary fibrosis) or high blood pressure in the lungs (pulmonary hypertension)
- People with an active infection near the tumour, skin infection at the planned procedure site that is not well controlled, a body-wide infection, or a high fever above 38.5°C
- People with serious problems affecting the liver, kidneys, heart, lungs, or brain, or severe anaemia, dehydration, or nutritional problems that cannot be corrected or improved in a short period of time
- People with a build-up of fluid around the lung (pleural effusion) that is not well controlled
- People who have been taking blood-thinning or anti-clotting medications (with some exceptions such as dabigatran and rivaroxaban) and have stopped taking them for fewer than 5–7 days before the procedure
- People with a functional status score greater than 2 on the ECOG scale, meaning people whose illness significantly limits their daily activity (confirm with trial site)
- People who have another cancer that has spread widely through the body, with an expected survival of less than 6 months
- People with episodic (recurring) psychiatric illness
- People who have an implanted electronic device such as a pacemaker or defibrillator
- People who are pregnant, or who plan to become pregnant during the study period
- People who are currently participating in, or have participated in, another clinical trial within the past 30 days
- People whom the trial investigators consider unsuitable for the study for other reasons
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jiayuan Sun, MD, PhD, Shanghai Chest Hospital
Phone: 86-021-22200000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Complete ablation rate at 6 months after ablation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.